EVRENZO Trademark

Trademark Overview

On Tuesday, June 19, 2018, a trademark application was filed for EVRENZO with the United States Patent and Trademark Office. The USPTO has given the EVRENZO trademark a serial number of 88005460. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 23, 2020. This trademark is owned by AstraZeneca AB. The EVRENZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, in particular, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
evrenzo

General Information

Serial Number88005460
Word MarkEVRENZO
Filing DateTuesday, June 19, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 23, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, in particular, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, November 23, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 23, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, April 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 16, 2020EXTENSION 2 GRANTED
Thursday, April 16, 2020EXTENSION 2 FILED
Thursday, April 16, 2020TEAS EXTENSION RECEIVED
Friday, October 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2019EXTENSION 1 GRANTED
Wednesday, October 2, 2019EXTENSION 1 FILED
Wednesday, October 2, 2019TEAS EXTENSION RECEIVED
Thursday, August 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 19, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, January 19, 2019ASSIGNED TO LIE
Friday, January 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 6, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 6, 2018NON-FINAL ACTION E-MAILED
Monday, August 6, 2018NON-FINAL ACTION WRITTEN
Monday, August 6, 2018ASSIGNED TO EXAMINER
Saturday, June 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 22, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

evrenzo diseases disorders anemia substances preparations pharmaceutical gastrointestinal nervous system inflammation